The literature reports mutations or deregulations in the EGF receptor, glutathione S transferase (GST), tongue cancer chemotherapy-resistance-associated protein 1 (TCRP1), and zinc finger E-box binding homeobox 1 (ZEB1) as potential contributors to chemotherapy resistance [27]. The gene discussed is FAM168A; the disease is tongue cancer.